Tracking the spread of sickness and disease

Public Health News

Select a news feed

Common bacteria on verge of becoming antibiotic-resistant superbugs

Sat, 28 Mar 2015 00:00:00 PDT

Antibiotic resistance is poised to spread globally among bacteria frequently implicated in respiratory and urinary infections in hospital settings, according to new research at Washington...

Phase 1 trial of first Ebola vaccine based on 2014 virus strain shows vaccine is safe and provokes an immune response

Fri, 27 Mar 2015 02:00:00 PDT

Results from the first phase 1 trial of an Ebola vaccine based on the current (2014) strain of the virus are published in The Lancet.

FDA approves treatment for inhalation anthrax

Fri, 27 Mar 2015 02:00:00 PDT

The U.S. Food and Drug Administration has approved Anthrasil, Anthrax Immune Globulin Intravenous (Human), to treat patients with inhalational anthrax in combination with appropriate antibacterial...

Whole virus vaccine for Ebola found to effectively protect monkeys

Fri, 27 Mar 2015 01:00:00 PDT

Scientists have developed a new vaccine to treat Ebola that uses an inactivated whole virus to hopefully provide a broader and more robust immune response.

Genetic discovery may offer new avenue of attack against schistosomiasis

Fri, 27 Mar 2015 00:00:00 PDT

Researchers at Oregon State University have discovered a group of genes in one species of snail that provide a natural resistance to the flatworm parasite that causes schistosomiasis, and opens the...

Discovery of what attracts pregnant mosquitos is used to fight malaria

Thu, 26 Mar 2015 03:00:00 PDT

The battle against malaria is also a battle against its natural host, the mosquito, which means disrupting the insect's lifecycle is every bit as important as putting nets over beds.

Ebola: £1 million grant to develop 'in the field' test

Thu, 26 Mar 2015 03:00:00 PDT

Public Health England (PHE) scientists are heading a consortium researching a rapid 'in the field' Ebola test, following the successful award of Innovative Medicines Initiative (IMI) funding.

To end TB, treat the missing millions

Thu, 26 Mar 2015 02:00:00 PDT

Every year, among the estimated 9 million persons who develop tuberculosis (TB), 3 million are missed - not diagnosed, treated, or even tracked by national TB programs - according to a Guest...

International health partners should learn from missteps in the early Ebola epidemic

Thu, 26 Mar 2015 02:00:00 PDT

Over the last year West Africa has suffered the worst Ebola outbreak in history involving over 22,000 cases and nearly 9,000 deaths.

Experiments reveal key components of the body's machinery for battling deadly tularemia

Thu, 26 Mar 2015 01:00:00 PDT

St. Jude Children's Research Hospital scientists have discovered major 'switches' that activate the immune system to kill the bacterium, potentially leading to protective drugs and...

Unraveling cystic fibrosis puzzle, taking it personally matters

Thu, 26 Mar 2015 01:00:00 PDT

In the genetic disorder cystic fibrosis (CF), the most severe symptoms are recurring episodes of lung inflammation and bacterial infection (known as "exacerbations") that happen from one to three...

Norovirus candidate vaccine induces broad antibody responses in trial participants

Thu, 26 Mar 2015 01:00:00 PDT

A multivalent candidate vaccine elicits broad antibody responses to a range of norovirus strains, including strains not included in the vaccine or previously encountered by participants, according to...

Young children 'at highest risk of death from Ebola,' study finds

Thu, 26 Mar 2015 00:00:00 PDT

A new study led by researchers from the WHO and Imperial College London in the UK finds that Ebola is more deadly for children aged 5 and under than older children and adults.

Quarantine yes/no?

Wed, 25 Mar 2015 04:00:00 PDT

Novel decision tree to assist policy and public health officialsThe recent Ebola outbreak highlighted the challenges to governments and local public health authorities in determining when...

Results of Pfizer's community‐acquired pneumonia immunization trial in adults (CAPiTA) published

Wed, 25 Mar 2015 02:00:00 PDT

Findings from the Community‐Acquired Pneumonia Immunization Trial in Adults (CAPiTA), published in The New England Journal of Medicine, demonstrate that Prevenar 13®(pneumococcal...

The health of travellers is being put at risk by a lack of knowledge on areas rife with disease

Wed, 25 Mar 2015 02:00:00 PDT

Experts are today warning of the negative implications that can come from using insect repellents that do not contain at least 20% DEET, and are fearful that young travellers are not fully aware of...

Rapid, accurate blood test can reduce antibiotic overuse by distinguishing bacterial & viral infections

Wed, 25 Mar 2015 02:00:00 PDT

MeMed, Ltd., has announced publication of the results of a large multicenter prospective clinical study that validates the ability of its ImmunoXpertTM in-vitro diagnostic blood test to determine...

Varied immunity by age 5 in children vaccinated with serogroup B meningococcus as babies

Wed, 25 Mar 2015 00:00:00 PDT

Young children who received the 4CMenB vaccine as infants to protect against serogroup B meningococcal disease had waning immunity by age 5, even after receiving a booster at age 3 ½, according to...

Comparing the genomes of the leprosy bacteria

Wed, 25 Mar 2015 00:00:00 PDT

Leprosy is a chronic infection of the skin, peripheral nerves, eyes and mucosa of the upper respiratory tract, affecting over a quarter million people worldwide.

Father inspired after child's autism improved by course of antibiotic

Wed, 25 Mar 2015 00:00:00 PDT

A surprising improvement in a child’s autism, seemingly caused by amoxicillin, has led a father to begin investigating the links between gut bacteria and the disorder.